<DOC>
	<DOCNO>NCT01153958</DOCNO>
	<brief_summary>This prospective , randomize , control multi-center trial ass use colposeptine female subject bacterial vaginosis . A total 480 subject plan enrol various center China .</brief_summary>
	<brief_title>Colposeptine Treatment Bacterial Vaginosis</brief_title>
	<detailed_description />
	<mesh_term>Vaginal Diseases</mesh_term>
	<mesh_term>Vaginosis , Bacterial</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<mesh_term>Chlorquinaldol</mesh_term>
	<criteria>Female subject reproductive age old 18 year Subjects normal sexual activity Subjects symptoms vulvavaginal irritation abnormal vaginal discharge Subjects Nugent Score great equal 7 Subjects willing use contraception Subjects willing refrain use vaginal product throughout study Subjects sign inform consent form agree followup time Subjects without sexual activity Pregnant lactate female subject Subjects history recurrent bacterial vaginosis Subjects diagnose trichomonas vaginitis，vulvovaginal candidiasis，chlamydia gonococcus infection . Subjects unwilling refrain ingestion alcoholic beverage 7 day course oral metronidazole therapy Subjects treatment lithium , phenobarbitone , coumadine anticoagulant , cyclosporine disulfiram time inclusion ( interaction product metronidazole ) Subjects undergoing systemic topical treatment antibiotic , steroid , immunosuppressive , cytostatic antimetabolic agent time inclusion Female subject history peripheral neuropathy Female subject participate another clinical trial take experimental drug within past 30 day Subjects unable give write informed consent</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Vaginosis , Bacterial</keyword>
	<keyword>Colposeptine</keyword>
	<keyword>Metronidazole</keyword>
</DOC>